Marston S B, Redwood C S
Department of Cardiac Medicine, National Heart and Lung Institute, London, United Kingdom.
J Biol Chem. 1993 Jun 15;268(17):12317-20.
We compared the mechanisms by which caldesmon inhibits actin and actin-tropomyosin activation of myosin subfragment 1 (S1) MgATPase activity. Caldesmon always inhibited actin activation by displacing S1.ADP.Pi from actin and inhibition required at least 0.7 caldesmon molecules bond per actin for 90% inhibition. Caldesmon inhibited actin-tropomyosin without any displacement of S1.ADP.Pi; thus it inhibits a rate-limiting step. Inhibition is highly cooperative, requiring no more than one caldesmon bound per 10 actins for 90% inhibition of activation by actin and smooth muscle tropomyosin. The degree of cooperativity is defined by the tropomyosin since inhibition by skeletal tropomyosin requires up to one caldesmon bound per 4 actins for 90% inhibition under identical conditions. Both noncooperative inhibition of actin and cooperative, tropomyosin-dependent, inhibition are manifested by a fragment of caldesmon containing only the C-terminal 99 amino acids (658C), although this fragment does not itself bind to tropomyosin. The functional properties of 658C are very similar to striated muscle troponin I, consequently we propose a similar mechanism for tropomyosin-dependent regulation by caldesmon. Caldesmon binding switches actin-tropomyosin to the "off" or "weak" state and Ca2+/calmodulin binding to caldesmon blocks this switch and thus reactivates the actin filament.
我们比较了钙调蛋白抑制肌动蛋白以及肌动蛋白-原肌球蛋白激活肌球蛋白亚片段1(S1)MgATP酶活性的机制。钙调蛋白总是通过将S1.ADP.Pi从肌动蛋白上置换下来来抑制肌动蛋白的激活,且抑制作用需要每分子肌动蛋白至少结合0.7个钙调蛋白分子才能达到90%的抑制率。钙调蛋白抑制肌动蛋白-原肌球蛋白时不会使S1.ADP.Pi发生任何位移;因此它抑制的是一个限速步骤。抑制作用具有高度协同性,每10个肌动蛋白结合不超过一个钙调蛋白就能对肌动蛋白和平滑肌原肌球蛋白激活产生90%的抑制。协同程度由原肌球蛋白决定,因为在相同条件下,骨骼肌原肌球蛋白产生90%抑制时每4个肌动蛋白需要结合多达一个钙调蛋白。仅包含C端99个氨基酸的钙调蛋白片段(658C)既能表现出对肌动蛋白的非协同抑制,也能表现出依赖原肌球蛋白的协同抑制,尽管该片段本身并不与原肌球蛋白结合。658C的功能特性与横纹肌肌钙蛋白I非常相似,因此我们提出钙调蛋白对依赖原肌球蛋白的调节存在类似机制。钙调蛋白的结合会将肌动蛋白-原肌球蛋白切换到“关闭”或“弱”状态,而Ca2+/钙调蛋白与钙调蛋白的结合会阻断这种切换,从而使肌动蛋白丝重新激活。